Related Experiment Video
Updated: Jul 12, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
An efficient system for intestinal on-site butyrate production using novel microbiome-derived esterases
Dah Hyun Jung1,2, Ji Hyun Yong1,2, Wontae Hwang1,2
1Department of Microbiology and Immunology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea.
Researchers identified novel microbial genes that efficiently convert tributyrin into beneficial butyrate. Engineered E. coli expressing these genes produced butyrate, alleviating colitis symptoms in mice, establishing a targeted delivery system.
Area of Science:
- Microbiology
- Gastroenterology
- Biotechnology
Background:
- Short-chain fatty acids, particularly butyrate, are crucial for gut health.
- Direct butyrate administration faces challenges, prompting interest in prodrugs like tributyrin (TB).
- Tributyrin is a triglyceride precursor that releases butyrate.
Purpose of the Study:
- To identify microbial enzymes capable of hydrolyzing tributyrin into butyrate.
- To develop a system for controlled, in-situ butyrate production in the intestine.
- To evaluate the therapeutic potential of this system in a colitis model.
Main Methods:
- Screening of a mouse microbiome metagenome library (5760 clones) for TB-hydrolyzing activity.
- Identification and sequence analysis of positive clones, including BLASTp for gene homology.
- Expression of candidate genes in Escherichia coli and assessment of butyrate production with TB.
- Evaluation of TB and engineered E. coli in a mouse model of acute colitis.
Main Results:
- Two bacterial clones efficiently hydrolyzed TB into butyrate.
- Homologous genes to acetylesterase/esterase were identified in unknown microbes.
- Proteins contained a conserved catalytic triad (serine-histidine-aspartate).
- E. coli expressing these genes produced significantly more butyrate in the presence of TB.
- Combined administration of TB and engineered E. coli reduced inflammatory symptoms in mice.
Conclusions:
- Novel esterase genes from uncultured microbes enable efficient TB hydrolysis.
- Engineered E. coli can serve as a platform for targeted intestinal butyrate production.
- This approach shows promise for managing inflammatory bowel conditions like colitis.
Related Concept Videos
Microbes in Food Production
Production of Organic Acids
Microbiota of the Stomach and Small Intestine
Microbiota of the Large Intestine
Functions of the Gut Microbiota
Dysbiosis of the Gut Microbiota

